Biodexa Pharmaceuticals Enrolls 100 Patients In Its Registrational Phase 3 Serenta Trial Of eRapa In Familial Adenomatous Polyposis; Trial Is Recruiting At 29 Clinical Sites In U.S., Canada And Europe And Is Expected To Be Initiated Shortly
Biodexa Licenses Phase 1-Ready Drug Candidate From Otsuka For Rare Stomach Cancer - Biodexa Pharmaceuticals (NASDAQ:BDRX), Cogent Biosciences (NASDAQ:COGT)